Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 67.72
+1.35 (2.03%)
At close: Mar 6, 2026
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 8.91 billion as of March 6, 2026. Its market cap has increased by 119.01% in one year.
Market Cap
8.91B
Enterprise Value
8.70B
Revenue
1.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
67.72
Market Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 8.91B, an increase of 102.37%. That is a compound annual growth rate of 11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.91B | 20.07% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Easton Biopharmaceuticals | 9.42B |
| Chongqing Genrix Biopharmaceutical | 9.39B |
| Bio-Thera Solutions | 8.82B |
| Sino Biological,Inc. | 8.42B |
| Daan Gene | 8.31B |
| Jiangxi Fushine Pharmaceutical | 8.22B |
| Chengdu Kanghua Biological Products | 7.97B |
| Youcare Pharmaceutical Group | 7.93B |